Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.56
-0.22 (-2.04%)
At close: Aug 18, 2025, 2:24 PM

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-36.64M -27.72M -20.59M -13.85M -11.78M -6.33M -4.15M -2.11M
Depreciation & Amortization
-649K 19K 16K 162K 101K 53K 51K 26K
Stock-Based Compensation
1.19M 605K 439K 335K 262K 208K 141K 72K
Other Working Capital
-2.9M -2.36M 775K 915K 167K -372K -498K -260K
Other Non-Cash Items
4.83M 276K 473K 385K 1.04M 1.08M 839K 742K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.64M -465K 1.57M 1.45M 1.23M 59K 378K -316K
Operating Cash Flow
-32.91M -27.29M -18.09M -11.52M -9.15M -4.93M -2.74M -1.58M
Capital Expenditures
-102K -104K -109K -103K -98K -5K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-124.65M -124.65M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
21.53M 12.03M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-11.89M -11.89M -11.89M n/a n/a n/a n/a n/a
Investing Cash Flow
-115.11M -124.62M -12M -103K -98K -5K n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.18M 81.83M 81.83M 83M 82.94M n/a n/a n/a
Financial Cash Flow
87.85M 170.87M 81.99M 83M 82.94M n/a n/a n/a
Net Cash Flow
-60.17M 18.96M 51.91M 71.39M 73.7M -4.94M -2.74M -1.58M
Free Cash Flow
-33.02M -27.39M -18.2M -11.62M -9.24M -4.94M -2.74M -1.58M